Register entry
- Registered sites
- 3
- Active NDC listings
- 5
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Analytical testing3Active ingredient (API) manufacture1Labelling2Finished drug manufacture2Packaging2
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Viwit Pharmaceutical Co., Ltd. | 389 West Shannan Road, Tengzhou Industrial Park, Shandong, China, Tengzhou, Shandong 277599, China (CHN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3008307561421161906 |
| Viwit Pharmaceutical Co., Ltd. | 88 Weizhi Road, Tengzhou Biopharma Park, Shandong, China, Tengzhou, Shandong 277514, China (CHN) | Analytical testing, Active ingredient (API) manufacture | 3009868618421281679 |
| Viwit Pharmaceutical Co., Ltd. | 369 Shengong Road, Zaozhuang High-tech Park, Shandong, China, Zaozhuang, Shandong 277000, China (CHN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3006068789530756485 |
Catalogue
Drug listings by form and route
55 active NDC listings: 3 human prescription drug, 2 bulk ingredient. By marketing category: ANDA 3, BULK INGREDIENT 2.
| Dosage form | NDCs |
|---|---|
| injection | 3 |
| powder | 2 |
| Route | NDCs |
|---|---|
| intravenous | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| viwit pharmaceutical co., ltd. | 3 |
| viwit pharmaceutical co ltd | 2 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Efinaconazole | powder | 42337-410BULK INGREDIENT |
| - | Varenicline Tartrate | powder | 42337-401BULK INGREDIENT |
| gadobutrol | gadobutrol | injection, intravenous | 42337-005ANDA |
| gadobutrol | gadobutrol | injection, intravenous | 42337-006ANDA |
| gadobutrol | gadobutrol | injection, intravenous | 42337-007ANDA |
Compare
Comparable companies in China
- Zhejiang Huahai Pharmaceutical Technology Co Ltd3 sites · 76 NDC
- Zhejiang Xianju Pharmaceutical Co., Ltd.3 sites · 38 NDC
- Zhejiang Hisun Pharmaceutical Co., Ltd.3 sites · 27 NDC
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.3 sites · 4 NDC
- Akeso Biopharma Co., Ltd3 sites · 1 NDC
- Shandong Xinhua Pharmaceutical Company Limited2 sites · 62 NDC
- Henan Lihua Pharmaceutical Co Ltd2 sites · 32 NDC
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.4 sites · 28 NDC
- BrightGene Bio-Medical Technology Co., Ltd.4 sites · 19 NDC
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.2 sites · 18 NDC
Enquiry
Common questions
- Is Viwit Pharmaceutical Co., Ltd. FDA approved?
- Viwit Pharmaceutical Co., Ltd. holds 3 FDA-registered establishments in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Viwit Pharmaceutical Co., Ltd.'s drugs manufactured?
- The FDA register lists Tengzhou; Zaozhuang. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
- What drugs does Viwit Pharmaceutical Co., Ltd. make?
- 5 products are listed under Viwit Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as injection; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.